Related news for: cancer care
Professor John Hooper and his team based at TRI, receives accolade that will allow them to progress ovarian cancer research to clinical trial.
Accolade for ovarian cancer research achievement
A drug currently in clinical trials has the potential to improve the survival rate of Australians diagnosed with acute myeloid leukaemia.
Mater research shows positive signs for acute myeloid leukaemia patients
Researchers from Mater Research are pioneering a new approach to symptom relief by trialling medicinal cannabis in advanced cancer patients, as part of an Australian-first trial.
Researchers trial medicinal cannabis treatment for advanced cancer patients
Mater Researcher Dr Felicity Davis has been awarded one of two $50,000 Metcalf Prizes from the National Stem Cell Foundation of Australia.
Dr Felicity Davis awarded Metcalf prize
A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.
New test predicts breast cancer patients at risk of relapse
Prof John Hooper & his team are working towards improving the diagnosis & treatment of ovarian cancer by developing a unique PET imaging agent that shows the exact location and extent of the tumour.
Increasing the visibility of cancer
Dr Cameron Turtle, a leading hematology oncologist and bone marrow transplant specialist at the Fred Hutchinson Cancer Research Center returned to Mater Research to share his latest research.
From Brisbane to Washington: former Mater researcher returns to share advances in cancer research
A Queensland trial will evaluate the benefits of medicinal cannabis for symptom relief in cancer patients receiving palliative care.
Medicinal cannabinoids trial for symptom relief